A. Markus

743 total citations
31 papers, 557 citations indexed

About

A. Markus is a scholar working on Molecular Biology, Pharmacology and Molecular Medicine. According to data from OpenAlex, A. Markus has authored 31 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Pharmacology and 12 papers in Molecular Medicine. Recurrent topics in A. Markus's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Microbial bioremediation and biosurfactants (4 papers). A. Markus is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Microbial bioremediation and biosurfactants (4 papers). A. Markus collaborates with scholars based in Germany, Israel and India. A. Markus's co-authors include Franz Lingens, N. Klesel, M. Limbert, Uwe Klages, Gerhard Seibert, E. Schrinner, Ernst Molitor, Heike Brötz, Gabriele Bierbaum and Hans‐Georg SAHL and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

A. Markus

31 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Markus Germany	11	210	177	150	113	70	31	557
Rex E. Hornish United States	12	76 0.4×	214 1.2×	167 1.1×	188 1.7×	108 1.5×	23	583
Krystyna Tyczkowska United States	17	130 0.6×	363 2.1×	62 0.4×	97 0.9×	109 1.6×	30	745
Soumya Ramu Australia	17	308 1.5×	150 0.8×	40 0.3×	180 1.6×	73 1.0×	19	764
Péter Laczay Hungary	15	94 0.4×	112 0.6×	148 1.0×	52 0.5×	149 2.1×	60	610
Joanna Deck United States	16	197 0.9×	104 0.6×	187 1.2×	193 1.7×	175 2.5×	32	703
Hyo‐In Yun South Korea	18	179 0.9×	247 1.4×	99 0.7×	56 0.5×	61 0.9×	55	732
Alejandro Luis Soraci Argentina	13	99 0.5×	232 1.3×	34 0.2×	52 0.5×	52 0.7×	61	673
Dimitris Kallifidas United States	17	683 3.3×	447 2.5×	125 0.8×	165 1.5×	37 0.5×	20	1.1k
Poul Nielsen United Kingdom	18	130 0.6×	425 2.4×	101 0.7×	93 0.8×	113 1.6×	45	920
Prem S. Jaglan United States	10	57 0.3×	209 1.2×	109 0.7×	133 1.2×	41 0.6×	23	430

Countries citing papers authored by A. Markus

Since Specialization

Citations

This map shows the geographic impact of A. Markus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Markus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Markus more than expected).

Fields of papers citing papers by A. Markus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Markus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Markus. The network helps show where A. Markus may publish in the future.

Co-authorship network of co-authors of A. Markus

This figure shows the co-authorship network connecting the top 25 collaborators of A. Markus. A scholar is included among the top collaborators of A. Markus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Markus. A. Markus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Markus, A., et al.. (2023). Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa. Infection and Drug Resistance. Volume 16. 5887–5898. 5 indexed citations

Markus, A., Nicolai Rosager Weber, Hans‐Michael Steffen, et al.. (2007). Pulmonale Nokardiose mit Trimethoprim/Sulfamethoxazol resistenter Nocardia paucivorans bei einem Patienten ohne Hinweise auf Immunsuppression. Pneumologie. 61(1). 46–51. 3 indexed citations

Klesel, N., et al.. (1995). Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. Journal of Antimicrobial Chemotherapy. 35(6). 805–819. 25 indexed citations

Klesel, N., M. Limbert, A. Markus, et al.. (1995). Activity of Levofloxacin, Ofloxacin, D-Ofloxacin and Ciprofloxacin against Systemic and Respiratory Tract Infections in Laboratory Animals. Drugs. 49(Supplement 2). 211–214. 1 indexed citations

Kern, Winfried V., et al.. (1994). Bacteremia due to fluoroquinolone-resistantEscherichia coli in two immunocompromised patients. European Journal of Clinical Microbiology & Infectious Diseases. 13(2). 161–165. 18 indexed citations

Klesel, N., et al.. (1992). Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs. Journal of Antimicrobial Chemotherapy. 29(suppl A). 31–37. 15 indexed citations

Seibert, Gerhard, et al.. (1992). The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 29(suppl A). 25–30. 25 indexed citations

Limbert, M., Gerhard Seibert, Irvin Winkler, et al.. (1992). Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases. Journal of Antimicrobial Chemotherapy. 29(suppl A). 13–17. 4 indexed citations

Klesel, N., et al.. (1992). RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo.. The Journal of Antibiotics. 45(6). 922–931. 3 indexed citations

10.

Bauernfeind, A., R. Jungwirth, N. Klesel, et al.. (1992). RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.. The Journal of Antibiotics. 45(4). 505–520. 12 indexed citations

11.

Markus, A., N. Klesel, M. Limbert, et al.. (1992). RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to .BETA.-lactamases and affinity for penicillin-binding proteins.. The Journal of Antibiotics. 45(4). 521–526. 2 indexed citations

12.

Klesel, N., et al.. (1990). Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.. The Journal of Antibiotics. 43(1). 100–106. 5 indexed citations

13.

Klesel, N., et al.. (1989). Synergistic antibacterial activity of cefotaxime and the penem HRE 664 in an improved in vitro model simulating serum and tissue pharmacokinetics.. PubMed. 1(4 Suppl). 479–81. 1 indexed citations

14.

Markus, A., et al.. (1986). Purification and some properties of component A of the 4-chlorophenylacetate 3,4-dioxygenase from Pseudomonas species strain CBS.. Journal of Biological Chemistry. 261(27). 12883–12888. 49 indexed citations

15.

Klages, Uwe, A. Markus, & Franz Lingens. (1981). Degradation of 4-chlorophenylacetic acid by a Pseudomonas species. Journal of Bacteriology. 146(1). 64–68. 34 indexed citations

16.

Ikan, Raphael, A. Markus, & Zeev Goldschmidt. (1973). Dichlorocarbene Chlorination of Steroids. Israel Journal of Chemistry. 11(4). 591–595. 1 indexed citations

17.

Ikan, Raphael, A. Markus, & Zeev Goldschmidt. (1972). Synthesis of steroidal cyclopropanes. Journal of the Chemical Society Perkin Transactions 1. 19. 2423–2423. 7 indexed citations

18.

Ikan, Raphael, A. Markus, & Ernst Bergmann. (1971). Synthesis of .beta.-sitosteryl acetate [(24 R)-24-ethyl-3.beta.-acetoxycholest-5-ene] and its 24 S epimer. The Journal of Organic Chemistry. 36(25). 3944–3945. 10 indexed citations

19.

Ikan, Raphael, et al.. (1970). Synthesis of campesteryl acetate ((24R)-24-methyl-3β-acetoxycholesten-5-ene) and its 24S-epimer. Steroids. 16(5). 517–522. 4 indexed citations

20.

Markus, A. & A G Spencer. (1955). Treatment of Chronic Lead-poisoning with Calcium Disodium Versenate. BMJ. 2(4944). 883–885. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact